Nanomedicine applied to cardiovascular diseases: latest developments

Area of Science:

• Biomedical Engineering
• Cardiovascular Medicine
• Nanotechnology

Background:

• Cardiovascular diseases (CVDs) are a leading cause of global mortality and disability.
• Current therapeutic options for CVDs often have insufficient efficacy and undesirable side effects.
• There is a critical need for advanced therapeutic strategies to manage CVD progression effectively.

Purpose of the Study:

• To explore novel technological approaches for treating cardiovascular diseases.
• To address the limitations associated with conventional cardiovascular therapies.
• To highlight advances in nanotechnology and controlled drug release for CVD management.

Main Methods:

• Review of recent scientific and technological developments in cardiovascular disease treatment.
• Focus on the application of nanotechnology in drug delivery systems.
• Investigation of controlled-release drug strategies for managing specific CVDs.

Main Results:

• Nanotechnology enables targeted drug delivery, potentially reducing side effects.
• Controlled-release systems offer sustained therapeutic levels, improving treatment efficacy.
• These advanced methods show promise for managing hyperlipidemia, hypertension, myocardial infarction, stroke, and thrombosis.

Conclusions:

• Nanotechnology and controlled drug release represent significant advancements in cardiovascular disease therapeutics.
• These innovative approaches can overcome many limitations of traditional treatments.
• Continued research in these areas is crucial for developing more effective CVD management strategies.